| ASSET | DATE | % RETURN |
|---|---|---|
BTCS (BTCS) | 12/31/2012 | 900% |
Capricor Therapeutics (CAPR) | 12/31/2012 | 73.93% |
Protagenic Therapeutics (PTIX) | 12/31/2012 | 72% |
Intrusion (INTZ) | 12/31/2012 | 63.27% |
Champions Oncology (CSBR) | 12/31/2012 | 42.86% |
Sobr Safe (SOBR) | 12/31/2012 | 42.77% |
Intellinetics (INLX) | 12/31/2012 | 40% |
Lightbridge (LTBR) | 12/31/2012 | 38.24% |
BioLife Solutions (BLFS) | 12/31/2012 | 36% |
GT Biopharma (GTBP) | 12/31/2012 | 32.67% |
Algorhythm (RIME) | 12/31/2012 | 30% |
Iovance Biotherapeutics (IOVA) | 12/31/2012 | 29.41% |
Xpel (XPEL) | 12/31/2012 | 27.78% |
Genasys (GNSS) | 12/31/2012 | 25% |
Nextplat (NXPL) | 12/31/2012 | 25% |
LifeMD (LFMD) | 12/31/2012 | 23.08% |
PharmaCyte Biotech (PMCB) | 12/31/2012 | 23% |
Hirequest (HQI) | 12/31/2012 | 22.73% |
VirTra (VTSI) | 12/31/2012 | 22.5% |
Forward Industries (FORD) | 12/31/2012 | 22.31% |
Orion Energy Systems (OESX) | 12/31/2012 | 21.17% |
Cryoport (CYRX) | 12/31/2012 | 20.58% |
Quest Resource (QRHC) | 12/31/2012 | 20.33% |
Cemtrex (CETX) | 12/31/2012 | 20% |
Tonix Pharmaceuticals (TNXP) | 12/31/2012 | 19.57% |
